181 related articles for article (PubMed ID: 861135)
1. The comparability of dosage regimens of Lanoxin tablets and Lanoxicaps.
Johnson BF; Smith G; French J
Br J Clin Pharmacol; 1977 Apr; 4(2):209-11. PubMed ID: 861135
[TBL] [Abstract][Full Text] [Related]
2. Comparison of steady-state serum concentrations of digoxin in tablets (Lanoxin) and capsules (Lanoxicaps) in the elderly.
Pouwels MJ; Hooymans PM; van der Aa GC; Gribnau FW
DICP; 1991 Oct; 25(10):1043-6. PubMed ID: 1803786
[TBL] [Abstract][Full Text] [Related]
3. The comparative bioavailability of Lanoxin tablets and Lanoxicaps with and without sorbitol.
O'Grady J; Johnson BF; Bye C; French J
Eur J Clin Pharmacol; 1978 Dec; 14(5):357-60. PubMed ID: 729628
[TBL] [Abstract][Full Text] [Related]
4. A completely absorbed oral preparation of digoxin.
Johnson BF; Bye C; Jones G; Sabey GA
Clin Pharmacol Ther; 1976 Jun; 19(6):746-51. PubMed ID: 1269214
[TBL] [Abstract][Full Text] [Related]
5. Biological availability of digoxin from Lanoxin produced in the United Kingdom.
Johnson BF; Fowle AS; Lader S; Fox J; Munro-Faure AD
Br Med J; 1973 Nov; 4(5888):323-6. PubMed ID: 4758424
[TBL] [Abstract][Full Text] [Related]
6. A radioimmunoassay for digoxin in human urine.
Marwaha RK; Johnson BF
J Clin Chem Clin Biochem; 1984 Jun; 22(6):403-6. PubMed ID: 6481305
[TBL] [Abstract][Full Text] [Related]
7. Effects of high-dose cancer chemotherapy on the absorption of digoxin in two different formulations.
Bjornsson TD; Huang AT; Roth P; Jacob DS; Christenson R
Clin Pharmacol Ther; 1986 Jan; 39(1):25-8. PubMed ID: 3943266
[TBL] [Abstract][Full Text] [Related]
8. Absorption of digoxin from tablets and capsules in subjects with malabsorption syndromes.
Heizer WD; Pittman AW; Hammond JE; Fitch DD; Bustrack JA; Hull JH
DICP; 1989 Oct; 23(10):764-9. PubMed ID: 2815851
[TBL] [Abstract][Full Text] [Related]
9. Absorption of digoxin from a new microencapsulated formulation.
Bergdahl B; Bogentoft C; Jonsson UE; Magnusson JO
Eur J Clin Pharmacol; 1980 Jun; 17(6):443-7. PubMed ID: 7398735
[TBL] [Abstract][Full Text] [Related]
10. A steady-state evaluation of the effects of propantheline bromide and cholestyramine on the bioavailability of digoxin when administered as tablets or capsules.
Brown DD; Schmid J; Long RA; Hull JH
J Clin Pharmacol; 1985; 25(5):360-4. PubMed ID: 4031112
[TBL] [Abstract][Full Text] [Related]
11. Transition from Lanoxin capsules to Lanoxin tablets in the debilitated elderly.
Drinka PJ; Nickel DA; Schomisch GW; Depka CH; Deterville RJ
DICP; 1990 Apr; 24(4):381-2. PubMed ID: 2327116
[TBL] [Abstract][Full Text] [Related]
12. Bioavailability studies with Digoxin-Sandoz and Lanoxin.
Beveridge T; Kalberer F; Nüesch E; Schmidt R
Eur J Clin Pharmacol; 1975 Jun; 8(5):371-6. PubMed ID: 1243983
[TBL] [Abstract][Full Text] [Related]
13. Digoxin bioavailability: formulations and rates of infusions.
Marcus FI; Dickerson J; Pippin S; Stafford M; Bressler R
Clin Pharmacol Ther; 1976 Sep; 20(3):253-9. PubMed ID: 954346
[TBL] [Abstract][Full Text] [Related]
14. A comparison of the bioavailability of digoxin in capsule, tablet, and solution taken orally with intravenous digoxin.
Binnion PF
J Clin Pharmacol; 1976 Oct; 16(10 Pt 1):461-7. PubMed ID: 977789
[TBL] [Abstract][Full Text] [Related]
15. Effect of magnesium--aluminum hydroxide and kaolin--pectin on absorption of digoxin from tablets and capsules.
Allen MD; Greenblatt DJ; Harmatz JS; Smith TW
J Clin Pharmacol; 1981 Jan; 21(1):26-30. PubMed ID: 7012189
[TBL] [Abstract][Full Text] [Related]
16. Bioavailability of digoxin capsules and tablets: effect of coadministered fluid volume.
Bustrack JA; Katz JD; Hull JH; Foster JR; Hammond JE; Christenson RH
J Pharm Sci; 1984 Oct; 73(10):1397-400. PubMed ID: 6502488
[TBL] [Abstract][Full Text] [Related]
17. An improvement in digoxin bioavailability. Studies with soft gelatin capsules containing a solution of digoxin.
Alvisi V; Longhini C; Bagni B; Portaluppi F; Ruina M; Fersini C
Arzneimittelforschung; 1979; 29(7):1047-50. PubMed ID: 582997
[TBL] [Abstract][Full Text] [Related]
18. Bioavailability and related heart function index of digoxin capsules and tablets in cardiac patients.
Astorri E; Bianchi G; La Canna G; Assanelli D; Visioli O; Marzo A
J Pharm Sci; 1979 Jan; 68(1):104-6. PubMed ID: 364006
[TBL] [Abstract][Full Text] [Related]
19. Variability of steady-state digoxin kinetics during administration of tablets or capsules.
Johnson BF; Lindenbaum J; Budnitz E; Marwaha R
Clin Pharmacol Ther; 1986 Mar; 39(3):306-12. PubMed ID: 3948469
[TBL] [Abstract][Full Text] [Related]
20. Maximal bioavailability of digoxin from tablets and oral solution in steady state.
Manninen V; Reissell P; Ojala K
Acta Med Scand; 1976; 199(6):487-9. PubMed ID: 937075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
